Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension-Reference-Cited by-同舟云学术

Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension

Published:2022-06-10 Issue:6 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Clement Freiberg Josefine¹,von Spreckelsen Alexander¹,Kolko Miriam²,Azuara-Blanco Augusto³,Virgili Gianni⁴

Affiliation:

1. Department of Drug Design and Pharmacology; University of Copenhagen; Copenhagen Denmark

2. Department of Ophthalmology and Department of Drug Design and Pharmacology; Copenhagen University Hospital, University of Copenhagen; Copenhagen Denmark

3. Centre for Public Health; Queen's University Belfast; Belfast UK

4. Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA); University of Florence; Florence Italy

Publisher

Wiley

Subject

Pharmacology (medical)

Reference103 articles.

1. Study of netarsudil ophthalmic solution in Japanese/Japanese-American subjects with open-angle glaucoma or ocular hypertension clinicaltrials.gov/ct2/show/results/NCT03310580

2. Phase 2 randomized clinical study of netarsudil ophthalmic solution in Japanese patients with primary open-angle glaucoma or ocular hypertension;Araie;Advanced Therapies,2021

3. Efficacy and systemic safety of netarsudil 0.01%, 0.02%, 0.04% relative to placebo in subjects with open-angle glaucoma or ocular hypertension in Japan clinicaltrials.gov/ct2/show/NCT03844945

4. Fixed-dose combination of netarsudil and latanoprost in ocular hypertension and open-angle glaucoma: pooled efficacy/safety analysis of phase 3 MERCURY-1 and -2;Asrani;Advanced Therapeutics,2020

5. Netarsudil/latanoprost fixed-dose combination for elevated intraocular pressure: three-month data from a randomized phase 3 trial;Asrani;American Journal of Ophthalmology,2019

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Narrative Review of Pharmacotherapy of Glaucoma;Future Pharmacology;2024-05-27

2. The Application of Rho Kinase Inhibitors in the Management of Glaucoma;International Journal of Molecular Sciences;2024-05-21

3. A NEW RP-UPLC METHOD FOR THE SEPARATION AND SIMULTANEOUS QUANTIFICATION OF DORZOLAMIDE HCl AND TIMOLOL MALEATE;International Journal of Applied Pharmaceutics;2024-05-07

4. The Role and Mechanism of Nicotinamide Riboside in Oxidative Damage and a Fibrosis Model of Trabecular Meshwork Cells;Translational Vision Science & Technology;2024-03-28

5. Efficacy and Safety of Rho Kinase Inhibitors vs. Beta-Blockers in Primary Open-Angle Glaucoma: A Systematic Review with Meta-Analysis;Journal of Clinical Medicine;2024-03-18